MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease

    D. Chouhan, A. Bello, K. Cullen, J. Duda (Philadelphia, USA)

    Objective: To create a three dimensional (3D) long-living model of human tissue-engineered nigrostriatal pathway (TE-NSP) comprised of discrete somatic and axonal compartments recapitulating the native…
  • 2025 International Congress

    Metabolic Imaging Correlates of Apathy in Parkinson’s Disease.

    J. Arena, M. Ponce-de-Leon, L. Fiorentini, C. Obarrio, S. Vazquez, Y. Bergamo, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate apathy-associated metabolic changes in Parkinson’s disease. Background: Apathy is a behavioral syndrome manifested as a decrease in goal-directed behaviors. It has been…
  • 2025 International Congress

    Spatial Multi-Omics Identifies Early Synaptic Pruning and Context-Specific Dopaminergic Vulnerability in Synucleinopathies

    S. Rumpf, F. Strübing, K. Nalbach, S. Lichtenthaler, C. Vargiu, P. Parchi, G. Höglinger, J. Herms, T. Koeglsperger (Munich, Germany)

    Objective: To investigate the significance of Lewy body pathology (LBP) in relation to midbrain molecular and cellular changes associated with Parkinson's disease (PD). Background: The…
  • 2025 International Congress

    Striatal dopamine- and basal forebrain cholinergic-dependent brain metabolism and cognition in Parkinson’s disease

    HS. Yoo, JH. Lee, M. Park, SJ. Ahn, JH. Lee, YH. Ryu, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To explore the interrelation of striatal dopamine, cholinergic basal forebrain volume, brain metabolism, and cognition in PD. Background: Parkinson’s disease (PD) involves multiple neurotransmitter…
  • 2025 International Congress

    STN Iron Content Correlates with DBS Efficacy in Parkinson’s Patients: a Preliminary Study

    G. Du, A. Snyder, J. Seemiller, L. Kong, P. Eslinger, J. Mcinerney, E. Farace, R. Mailman, X. Huang, S. de Jesus (Hersehy, USA)

    Objective: Evaluate the relationship between baseline iron levels in the subthalamic nucleus (STN) and their impact on motor function and dopaminergic medication needs after deep…
  • 2025 International Congress

    Sex-specific genetic architecture of autosomal risk for Parkinson’s Disease: from the Global Parkinson’s Genetics Program

    GP2. Parkisnon'S_genetics_program (Bethesda, USA)

    Objective: To investigate potential differences in autosomal risk factors between males and females with Parkinson’s Disease (PD). This analysis was performed within and across genetically…
  • 2025 International Congress

    Returning Secondary Health Findings in the PD GENEration study

    M. Dini, K. Ghosh Galvelis, N. Bothwick, L. Caboy, M. Caulfield, R. de Leon, A. Dilliott, I. Khaderi, S. Rao, A. Yake, A. Coral Zambrano, R. Bhisetti, S. Lawrence, S. Li, Y. Lu, U. Ragunathan, T. Foroud, V. Caceres, L. Cook, K. Fiallos, L. Heathers, R. Hodges, A. Miller, A. Neibaur, M. Rumbaugh, M. Totten, J. Verbrugge, A. Hall, K. Marder, I. Mata, N. Mencacci, M. Nance, T. Simuni, M. Schwarzschild, A. Wills, H. Gao, C. Blauwendraat, J. Beck, R. Alcalay (Miami, USA)

    Objective: To provide secondary health findings (SHF) results to participants enrolled in the PD GENEration study via CLIA genetic testing using whole genome sequencing (WGS)…
  • 2025 International Congress

    Identifying Differential DNA Methylation Pathways in Parkinson’s Disease and REM Sleep Behavior Disorder

    Z. Wu, C. Song, J. Ruiz Tejeda, R. Rajmohan, R. Malhas, M. Mapstone, W. Li, N. Phielipp (Irvine, USA)

    Objective: To investigate differential methylation patterns of cell-free DNA (cfDNA) between Parkinson’s Disease (PD), REM Sleep Behavior Disorder (RBD), and Healthy Control (HC) groups. Background:…
  • 2025 International Congress

    Studying the Influence of Genetic Variations on Functional Performance in Parkinson’s Disease

    D. Moss, K. Smaller, M. Rafferty, P. Gonzalez-Latapi (Chicago, USA)

    Objective: To evaluate whether individuals with one of the seven most common genetic variants associated with Parkinson’s Disease (PD) exhibit differences in physical function performance…
  • 2025 International Congress

    Revealing Novel Genetic Contributors to Parkinson’s Disease in a Chinese Cohort: An Elaborate Examination within the CPD10KGP

    Z. Liu, Y. Zhao, H. Pan, B. Tang (Changsha, China)

    Objective: This study employs next-generation sequencing (NGS) and long-read sequencing data (LRS) in Chinese AR-PD families to uncover novel genes, enhancing our genetic comprehension of PD. Background:…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley